Results 301 to 310 of about 143,193 (344)
Indian J PharmacolSome of the next articles are maybe not open access.
Related searches:
Related searches:
Contact Dermatitis, 2022
AbstractBackgroundCosmetic adverse reactions (CARs) are becoming widespread in China. However, a comprehensive analysis of data is lacking.ObjectiveTo analyse the clinical characteristics of patients with reported adverse reactions to cosmetics in Chongqing, China.MethodsCases with CARs reported to the Chongqing Adverse Drug Reaction Monitoring Centre ...
Sha Wang +4 more
openaire +2 more sources
AbstractBackgroundCosmetic adverse reactions (CARs) are becoming widespread in China. However, a comprehensive analysis of data is lacking.ObjectiveTo analyse the clinical characteristics of patients with reported adverse reactions to cosmetics in Chongqing, China.MethodsCases with CARs reported to the Chongqing Adverse Drug Reaction Monitoring Centre ...
Sha Wang +4 more
openaire +2 more sources
Adverse reactions to isotretinoin
Journal of the American Academy of Dermatology, 1988Between October 1982 and June 1985 the Adverse Drug Reaction Reporting System received reports of 104 suspected adverse reactions occurring in 93 patients who took isotretinoin. Adverse reactions involving the skin and mucous membranes (29 reports), central nervous system (23), musculoskeletal system (12), pregnancy (11), and eyes (8) were most ...
Robert S. Stern, Michael Bigby
openaire +3 more sources
Adverse drug reactions in adolescents: a review of reporting to a national pharmacovigilance system
Expert Opinion on Drug Safety, 2020Adverse drug reactions (ADR) cause significant morbidity, mortality and health costs and have an important prevalence in all ages. Few studies focus on ADR in adolescents. The goal of this study was to characterize a case series of ADR reported to the Portuguese Pharmacovigilance System (PPS) of the National Authority of Medicines and Health Products ...
Eva Rebelo Gomes +3 more
openaire +3 more sources
Efficacy of reporting systems of adverse reactions to drugs and care.
Scandinavian journal of social medicine, 1983Only 13% of adverse drug reactions that should have been reported to the Committee on Side Effects in Sweden according to the criteria published by the National Board of Health and Welfare, were actually reported by the responsible doctors. This was found in a prospective study of all adverse reactions established in 1 271 patients at a department of ...
Britton S, Jorup-Rönström C
openaire +3 more sources
System for voluntary reporting of adverse drug reactions in a university hospital
American Journal of Health-System Pharmacy, 1989The development and implementation of a system to improve voluntary reporting of adverse drug reactions (ADRs) is described. A preliminary study comparing three concurrent voluntary reporting systems at a 327-bed university teaching hospital demonstrated the ability of medical records personnel to identify ADRs that were documented in the medical ...
Lynda Barstow +2 more
openaire +3 more sources
Developing an Adverse Drug Reaction Reporting System at a Teaching Hospital
Basic & Clinical Pharmacology & Toxicology, 2008Abstract: Adverse drug reactions (ADRs) are a frequent cause for hospitalization and occur often in hospitalized patients. The objective of this study was to establish an ADR reporting and monitoring system at a teaching hospital. The pharmacovigilance unit of Masih Daneshvari hospital was established by a clinical pharmacist and a clinical ...
Fanak Fahimi +2 more
openaire +3 more sources
Patient satisfaction with a hospital adverse drug reaction reporting system
Journal of Pharmacy Practice and Research, 2020AbstractAimTo evaluate patients' satisfaction with the adverse drug reactions (ADR) warning card model used within a metropolitan hospital network in Melbourne, Australia.Methods and ResultsA cross‐sectional survey, with interviewer‐administered questionnaire, of patients who experienced an ADR was conducted.
Matthew W. Scott +4 more
openaire +2 more sources
Respiratory Care, 2021
Between 2012 and 2017, 25 new medications or combination products were approved by the Food and Drug Administration (FDA) for use in treatment of chronic lower respiratory diseases (CLRDs). With limited data on post-marketing patient exposure to these drugs, their safety profiles remain unknown. This study aims to provide post-marketing surveillance of
Sandra L. Kane-Gill +5 more
openaire +3 more sources
Between 2012 and 2017, 25 new medications or combination products were approved by the Food and Drug Administration (FDA) for use in treatment of chronic lower respiratory diseases (CLRDs). With limited data on post-marketing patient exposure to these drugs, their safety profiles remain unknown. This study aims to provide post-marketing surveillance of
Sandra L. Kane-Gill +5 more
openaire +3 more sources
Identifying adverse reactions to drugs reporting systems
Clinics in Dermatology, 1986Abstract The dermatologist's concern about adverse reactions to drugs can be viewed from two perspectives. Most often, dermatologists are confronted with skin reactions to drugs used in the treatment of a wide variety of noncutaneous diseases. Less frequently, but sometimes more dramatically, dermatologists care for a patient who may have developed a ...
openaire +3 more sources